BeStock  
Stocks › Biotechnology › ANRO

Alto Neuroscience ANRO

US equityMarket cap rank #3145Biotechnology
$25.37 −$1.14 (-4.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.37 0.00%
Open$25.76
Prev close$26.51
Day range$24.40 – $26.48
Volume522.5K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

ANRO at a glance

Alto Neuroscience stock (ANRO) sits at $25.37, down 4.30% today. The business is worth $1.02B in the market, good for #3145 of 3753 on our coverage list.

Over a full year the shares have ranged across $12.51 to $37.48, which puts the current price roughly 52% of the way up that band. Holders are ahead 91.5% over twelve months, but down 30.0% across the last three months.

Price is below the 50-day average ($25.58) but above the 200-day ($25.00); RSI is 49, and the last 30 sessions moved at roughly 88% annualized volatility.

Revenue for the quarter ended Sep 2026 was $0.00, and a net loss of $25.12M.

5 analysts follow the stock and the average call is "buy". The mean target, $47.00, sits 85.3% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$21.46 / $35.00
Average price today$25.38
Volume522.5KAvg (90d) 566.9K
Turnover$13.26M
Turnover rate1.72%of shares outstanding
Volume ratio0.76vs. recent average pace
Day amplitude7.85%
Market cap$1.02B
Float market cap$772.85M
Shares outstanding30.46M
EPS (TTM)-$2.19
P/B3.43
Book value / share$7.39
Net profit (TTM)-$87.84M
Net assets$296.54M
30-day volatility87.8%annualized
Avg daily range (ATR)9.38%of price, 14 days
Max drawdown (1y)-40.7%-30.8% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

B
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

D
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

5 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 45.0 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability2.7
Momentum59.1
Financial health63.5
Analyst view88.3

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$47.00+85.3% vs. current price
Consensus ratingBuy5 analysts covering
Morningstar fair value$40.09Price is below fair value

Wall Street’s average 12-month target is $47.00, 85.3% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $40.09, so shares trade 36.7% below that estimate. On earnings multiple, it sits in the 5th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-4.3%
1 week
-14.1%
1 month
+14.3%
3 months
-30.0%
6 months
+19.6%
Year to date
+42.5%
1 year
+91.5%
Day range
$24.40$26.48
52-week range
$12.51$37.48

Technical signals

Full technicals →
Trend readLeaning bearish

3 bullish · 4 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average0.0%Bearish
Price vs 50-day average-0.8%Bearish
Price vs 200-day average+1.5%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)48.5Bearish
MACD (12,26,9)0.50Bullish
Bollinger band position50%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How ANRO ranks on BeStock

Market value#3132 of 3734
Closeness to 52-week high#2285 of 3724
Dollar volume today#2261 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

ANRO is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on ANRO.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on ANRO

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

ANRO stock: common questions

Where is ANRO trading right now?

$25.37 is the latest print for ANRO, a move of -4.30% against yesterday's close of $26.51. Today's low and high so far: $24.40 and $26.48.

How big is Alto Neuroscience?

Equity value comes to $1.02B at the current price. By that measure it is number 3145 of the 3753 names in our coverage.

Where does ANRO sit in its 52-week range?

The year's floor is $12.51 and the ceiling $37.48. Shares are 32.3% away from that ceiling.

Does ANRO send cash back through a dividend?

Our data shows no dividend paid by Alto Neuroscience over the trailing twelve months.

Do Wall Street analysts like ANRO?

Of 5 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $47.00, with the most cautious at $37.00 and the most optimistic at $60.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on ANRO.

Sign in to join the discussion.

Scroll to Top